Relay Therapeutics, Inc. (RLAY)

NASDAQ: RLAY · Real-Time Price · USD

19.93

-0.14 (-0.70%)

At close: Aug 13, 2026, 4:00 PM EDT

19.99

+0.06 (0.30%)

Pre-market: Aug 14, 2026, 6:01 AM EDT

Relay Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,367	1,471	691	1,403	1,809	3,323
Market Cap Growth	679.44%	112.82%	-50.75%	-22.44%	-45.55%	-11.06%
Enterprise Value	3,487	948.87	-41.67	706.74	868.24	2,388
Last Close Price	19.93	8.46	4.12	11.01	14.94	30.71
PS Ratio	421.98	95.79	69.07	54.93	1310.22	1097.11
PB Ratio	4.89	2.59	0.89	1.87	1.90	3.70
P/TBV Ratio	4.08	2.56	0.76	1.80	1.77	3.26
EV/Sales Ratio	336.93	61.80	-4.16	27.67	628.71	788.37
EV/EBITDA Ratio	-	-	0.11	-	-	-
EV/EBIT Ratio	-	-	0.11	-	-	-
EV/FCF Ratio	-	-	0.17	-	-	-
Debt / Equity Ratio	0.03	0.05	0.05	0.06	0.06	0.02
Net Debt / Equity Ratio	-0.99	-0.92	-0.94	-0.93	-0.99	-1.04
Net Debt / EBITDA Ratio	2.86	1.75	2.00	1.89	3.19	2.59
Net Debt / FCF Ratio	4.15	2.21	2.92	2.29	3.95	12.01
Asset Turnover	0.01	0.02	0.01	0.03	0.00	0.00
Quick Ratio	17.93	21.68	15.40	24.78	15.68	39.41
Current Ratio	18.27	22.61	15.95	25.44	16.00	40.14
Return on Equity (ROE)	-39.26%	-41.12%	-44.15%	-40.18%	-31.44%	-43.81%
Return on Assets (ROA)	-39.08%	-40.56%	-43.43%	-38.38%	-28.39%	-40.34%
Return on Invested Capital (ROIC)	-688.28%	-528.17%	-507.93%	-456.60%	-504.73%	-507.58%
Return on Capital Employed (ROCE)	-41.05%	-42.75%	-45.58%	-40.33%	-29.63%	-41.20%
Buyback Yield / Dilution	-12.39%	-20.10%	-16.55%	-9.22%	-17.97%	-123.22%
Total Shareholder Return	-12.39%	-20.10%	-16.55%	-9.22%	-17.97%	-123.22%

SEC Filings: 10-K · 10-Q